Humana (NYSE:HUM) Coverage Initiated by Analysts at Evercore ISI

Key Points

• Evercore ISI has initiated coverage on Humana (NYSE:HUM) with an "in-line" rating and a price target of $295.00, indicating a potential upside of 16.88% from the current stock price.
• Currently, Humana has a consensus rating of "Hold" with 7 analysts rating it as a Buy and 17 as a Hold, and a consensus target price of $289.50.
• Humana's recent quarterly earnings showed a miss with EPS of $6.27, falling short of analysts' estimates of $6.32, but revenue saw a year-over-year increase of 9.6% to $32.39 billion.

Research analysts at Evercore ISI started coverage on shares of Humana (NYSE:HUM - Get Free Report) in a report released on Monday, MarketBeat Ratings reports. The brokerage set an "in-line" rating and a $295.00 price target on the insurance provider's stock. Evercore ISI's price target indicates a potential upside of 14.30% from the company's current price.

Other equities research analysts also recently issued research reports about the stock. Wall Street Zen downgraded shares of Humana from a "buy" rating to a "hold" rating in a report on Saturday, August 2nd. Piper Sandler cut their price target on shares of Humana from $288.00 to $272.00 and set a "neutral" rating for the company in a report on Thursday, July 31st. Royal Bank Of Canada upped their price target on shares of Humana from $283.00 to $322.00 and gave the company an "outperform" rating in a report on Thursday, August 21st. Morgan Stanley cut their price target on shares of Humana from $290.00 to $277.00 and set an "equal weight" rating for the company in a report on Thursday, July 31st. Finally, Robert W. Baird cut their price target on shares of Humana from $300.00 to $297.00 and set a "neutral" rating for the company in a report on Friday, July 25th. Seven equities research analysts have rated the stock with a Buy rating and seventeen have given a Hold rating to the company's stock. According to data from MarketBeat, the company has a consensus rating of "Hold" and a consensus price target of $289.50.

Humana Stock Performance

Shares of Humana stock traded up $5.43 during trading on Monday, hitting $258.09. 1,926,931 shares of the stock were exchanged, compared to its average volume of 1,845,160. The stock's fifty day moving average is $269.18 and its 200 day moving average is $257.22. The stock has a market cap of $31.04 billion, a PE ratio of 19.81, a P/E/G ratio of 1.48 and a beta of 0.44. The company has a debt-to-equity ratio of 0.69, a quick ratio of 1.95 and a current ratio of 1.95. Humana has a 12 month low of $206.87 and a 12 month high of $324.38.

Humana (NYSE:HUM - Get Free Report) last released its quarterly earnings results on Wednesday, July 30th. The insurance provider reported $6.27 EPS for the quarter, missing the consensus estimate of $6.32 by ($0.05). The firm had revenue of $32.39 billion for the quarter, compared to the consensus estimate of $31.85 billion. Humana had a return on equity of 13.67% and a net margin of 1.28%.The firm's revenue was up 9.6% on a year-over-year basis. During the same quarter in the prior year, the company posted $6.96 EPS. Humana has set its FY 2025 guidance at 17.000- EPS. As a group, sell-side analysts anticipate that Humana will post 16.47 EPS for the current year.

Hedge Funds Weigh In On Humana

Several institutional investors and hedge funds have recently added to or reduced their stakes in the company. Cary Street Partners Investment Advisory LLC lifted its position in shares of Humana by 63.9% in the first quarter. Cary Street Partners Investment Advisory LLC now owns 118 shares of the insurance provider's stock worth $31,000 after purchasing an additional 46 shares in the last quarter. Elevation Point Wealth Partners LLC purchased a new stake in shares of Humana in the second quarter worth approximately $32,000. Riverview Trust Co purchased a new stake in shares of Humana in the first quarter worth approximately $34,000. Garde Capital Inc. purchased a new stake in shares of Humana in the first quarter worth approximately $36,000. Finally, Zions Bancorporation National Association UT purchased a new stake in shares of Humana in the first quarter worth approximately $37,000. 92.38% of the stock is currently owned by hedge funds and other institutional investors.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.